COMMUNITY PRACTICE TOWARDS LYMPHATIC FILARIASIS AND MASS DRUG ADMINISTRATION IN PEMAYUNG SUBDISTRICT OF BATANGHARI DISTRICT, JAMBI

被引:0
|
作者
Ambarita, Lasbudi P. [1 ]
Taviv, Yulian [1 ]
Sitorus, Hotnida [1 ]
Pahlepi, R. Irpan [1 ]
Kasnodihardjo [2 ]
机构
[1] Baturaja Badan Litbangkes, Loka Penelitian Pengembangan Pengendalian Penyaki, Baturaja, Sumatera Selata, Indonesia
[2] Badan Litbangkes, Pusat Teknol Terapan Intervensi Kesehatan Masyara, Jakarta, Indonesia
来源
MEDIA PENELITIAN DAN PENGEMBANGAN KESEHATAN | 2014年 / 24卷 / 04期
关键词
Lymphatic filariasis; Practice; Mass Drug Administration; Pemayung Subdistrict;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Lymphatic filariasis (LF) is an infectious disease transmitted by mosquitoes that carries parasitic filarial worms. One of the efforts made at the national and global levels in the filariasis elimination program is the mass drug administration (MDA). This study aims to determine practice towards lymphatic filariasis and mass drug administration among population at Pemayung Subdistrict of Batanghari District, Jambi and carried out before the third MDA in 2011. This research is a non-intervention study with cross-sectional design. Sample units is households and a total of 374 households had been selected randomly. A practice questionnaire was used to collect data on practice regarding LF and responses to MDA. The results showed for risky behaviour among the respondents, 45.5% said often going out at night with various kinds of activity, 99.5% using protection to avoid mosquito bites, 7.5% have follow blood test for microfilaria detection and 5.4% having experienced periodic fever. Most of respondents (86.6%) know the distribusion of LF drugs in their villages, 69.1% of them ever heard socialization of MDA and 86.1% had been given the drug. Of 324 respondents that had been given a drug, 76% ever consume drug and 41% of them consume it once time while 24% didn't consumpt the drugs with the main reason was fear of side reaction (50.8%). There were correlation (p<0.05) between age, sex, MDA campaign, distribution of medicinewithdrinking medicine compliance.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 50 条
  • [41] MID TERM ASSESSMENT OF MASS DRUG ADMINISTRATION IN LYMPHATIC FILARIASIS ENDEMIC AREA OF DAMOH AND SAGAR DISTRICT OF MADHYA PRADESH
    Shinde, Mohan
    Saraf, Yash
    Joshi, Ankur
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2015, 4 (24): : 4121 - 4127
  • [42] Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration
    Cabral, Silvia
    Bonfim, Cristine
    Oliveira, Rosalira
    Oliveira, Paula
    Guimaraes, Terezinha
    Brandao, Eduardo
    Aguiar-Santos, Ana Maria
    Medeiros, Zulma
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2017, 59
  • [43] Persistent 'hotspots' of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana
    Biritwum, Nana-Kwadwo
    Yikpotey, Paul
    Marfo, Benjamin K.
    Odoom, Samuel
    Mensah, Ernest O.
    Asiedu, Odame
    Alomatu, Bright
    Hervie, Edward T.
    Yeboah, Abednego
    Ade, Serge
    Hinderaker, Sven G.
    Reid, Anthony
    Takarinda, Kudakwashe C.
    Koudou, Benjamin
    Koroma, Joseph B.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2016, 110 (12) : 690 - 695
  • [44] Predictors of compliance with a mass drug administration programme for lymphatic filariasis in Orissa State, India 2008
    Cantey, P. T.
    Rao, G.
    Rout, J.
    Fox, L. M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (02) : 224 - 231
  • [45] Inadvertent exposure of pregnant women to ivermectin and albendazole during mass drug administration for lymphatic filariasis
    Gyapong, JO
    Chinbuah, MA
    Gyapong, M
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2003, 8 (12) : 1093 - 1101
  • [46] Beyond business as usual for lymphatic filariasis mass drug administration in hotspot districts
    de Souza, Dziedzom K.
    Sumboh, Jeffrey G.
    Laryea, Nii A.
    Asiedu, Odame
    Alomatu, Bright
    Mensah, Sedzro K.
    Otchere, Joseph
    Opare, Joseph Larbi
    Ahorlu, Collins S.
    INTERNATIONAL HEALTH, 2025,
  • [47] Individual Efficacy and Community Impact of Ivermectin, Diethylcarbamazine, and Albendazole Mass Drug Administration for Lymphatic Filariasis Control in Fiji: A Cluster Randomized Trial
    Hardy, Myra
    Samuela, Josaia
    Kama, Mike
    Tuicakau, Meciusela
    Romani, Lucia
    Whitfeld, Margot J.
    King, Christopher L.
    Weil, Gary J.
    Grobler, Anneke C.
    Robinson, Leanne J.
    Kaldor, John M.
    Steer, Andrew C.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (06) : 994 - 1002
  • [48] Coverage and compliance of mass drug administration (MDA) programme for elimination of lymphatic filariasis in an endemic district of eastern Uttar Pradesh, India
    Bashar, Abu
    Nandekar, Sanket, V
    Shrivastava, Prerna
    Singh, Ravi Nandini
    Srikrishnan, Pushkar
    JOURNAL OF VECTOR BORNE DISEASES, 2023, 60 (03) : 307 - 316
  • [49] Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, Philippines
    Maria Lourdes E Amarillo
    Vicente Y Belizario
    Jewel T Sadiang-abay
    Stephanie Anne M Sison
    Ariane Marie S Dayag
    Parasites & Vectors, 1
  • [50] Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration
    Simonsen, Paul E.
    Derua, Yahya A.
    Magesa, Stephen M.
    Pedersen, Erling M.
    Stensgaard, Anna-Sofie
    Malecela, Mwelecele N.
    Kisinza, William N.
    PARASITES & VECTORS, 2014, 7